Indirect resistance to several classes of antibiotics in cocultures with resistant bacteria expressing antibiotic-modifying or -degrading enzymes

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 1, 2016, Pages 100-110

  Nicoloff H , Herve ^a   Andersson, Dan I ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE CTX M; CHLORAMPHENICOL; CLARITHROMYCIN; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; KANAMYCIN; MECILLINAM; SPECTINOMYCIN; STREPTOMYCIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; CULTURE MEDIUM; ENZYME;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM; CATALYSIS; CONTROLLED STUDY; DRUG DEGRADATION; INDIRECT RESISTANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; BIOTRANSFORMATION; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECTS; HUMAN; METABOLISM; MICROBIAL CONSORTIUM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY;

ANTI-BACTERIAL AGENTS; BACTERIA; BIOTRANSFORMATION; CULTURE MEDIA; ENZYMES; HUMANS; MICROBIAL CONSORTIA; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY;

EID: 84960173009     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv312     Document Type: Article

References (45)

1. Maddocks JL, May JR. 'Indirect pathogenicity' of penicillinase-producing enterobacteria in chronic bronchial infections. Lancet 1969; 1(7599): 793-5.
2. Jackson DM, Lowbury EJ, Topley E. Chemotherapy of Streptococcus pyogenes infection of burns. Lancet 1951; 2(6686): 705-11.
3. Brook I. The role of b-lactamase-producing-bacteria in mixed infections. BMC Infect Dis 2009; 9: 202.
4. Liao YT, Kuo SC, Lee YT et al. Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection. Antimicrob Agents Chemother 2014; 58: 3983-90.
5. Brook I. The role of b-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 601-7.
6. Georgiou G, Shuler ML, Wilson DB. Release of periplasmic enzymes and other physiological effects of b-lactamase overproduction in Escherichia coli. Biotechnol Bioeng 1988; 32: 741-8.
7. Tanco JM, Del Pilar Miravalles M, Arcos JM. Extracellular b-lactamase from Escherichia coli. Arch Mikrobiol 1970; 72: 16-22.
8. Haller I. Importance of extracellular and cell-bound b-lactamase in mediating resistance of Staphylococcus aureus to mezlocillin. Antimicrob Agents Chemother 1984; 25: 125-7.
9. O'Connell HA, Kottkamp GS, Eppelbaum JL et al. Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm. Appl Environ Microbiol 2006; 72: 5013-9.
10. D'Costa VM, McGrann KM, Hughes DW et al. Sampling the antibiotic resistome. Science 2006; 311: 374-7.
11. Szczepanowski R, Linke B, Krahn I et al. Detection of 140 clinically relevant antibiotic-resistance genes in the plasmid metagenome of wastewater treatment plant bacteria showing reduced susceptibility to selected antibiotics. Microbiology 2009; 155: 2306-19.
12. Hu Y, Yang X, Qin J et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun 2013; 4: 2151.
13. Baba T, Ara T, Hasegawa M et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006; 2: 2006.0008.
14. Datsenko KA,Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97: 6640-5.
15. Kitagawa M, Ara T, Arifuzzaman M et al. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res 2005; 12: 291-9.
16. Andremont A, Gerbaud G, Courvalin P. Plasmid-mediated high-level resistance to erythromycin in Escherichia coli. Antimicrob Agents Chemother 1986; 29: 515-8.
17. Brolund A, Franzen O, Melefors O et al. Plasmidome-analysis of ESBL-producing Escherichia coli using conventional typing and highthroughput sequencing. PLoS One 2013; 8: e65793.
18. Thanassi DG, Suh GS, Nikaido H. Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli. J Bacteriol 1995; 177: 998-1007.
19. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 2003; 67: 593-656.
20. Mortimer PG, Piddock LJ. The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J Antimicrob Chemother 1993; 32: 195-213.
21. Kahan FM, Kahan JS, Cassidy PJ et al. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 1974; 235: 364-86.
22. TaberHW, Mueller JP, Miller PF et al. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 1987; 51: 439-57.
23. Rosenberg EY, Ma D, Nikaido H. AcrD of Escherichia coli is an aminoglycoside efflux pump. J Bacteriol 2000; 182: 1754-6.
24. Dufour D, Leung V, Lévesque M. Bacterial biofilm: structure, function, and antimicrobial resistance. Endod Topics 2012; 22: 2-16.
25. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 1994; 264: 382-8.
26. Corona F, Martinez JL. Phenotypic resistance to antibiotics. Antibiotics 2013; 2: 237-55.
27. Thaker M, Spanogiannopoulos P, Wright GD. The tetracycline resistome. Cell Mol Life Sci 2010; 67: 419-31.
28. Roberts MC, Schwarz S. Tetracycline and chloramphenicol resistance mechanisms. In: Mayers DL, Lerner SA, Ouelette M et al., eds. Antimicrobial Drug Resistance. New York: Humana Press, 2009; 183-93.
29. Canu M, Leclercq R. Macrolides and lincosamides. In: Mayers DL, Lerner SA, Ouelette M et al., eds. Antimicrobial Drug Resistance. New York: Humana Press, 2009; 211-21.
30. Michalopoulos AS, Livaditis IG, Gougoutas V. The revival of fosfomycin. Int J Infect Dis 2011; 15: e732-9.
31. D'Costa V, Wright GD. Biochemical logic of antibiotic inactivation and modification. In: Mayers DL, Lerner SA, Ouelette M et al., eds. Antimicrobial Drug Resistance. New York: Humana Press, 2009; 81-95.
32. D'Costa VM, Mukhtar TA, Patel T et al. Inactivation of the lipopeptide antibiotic daptomycin by hydrolytic mechanisms. Antimicrob Agents Chemother 2012; 56: 757-64.
33. Robicsek A, Strahilevitz J, Jacoby GA et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006; 12: 83-8.
34. Finegold SM. In vitro efficacy of b-lactam/b-lactamase inhibitor combinations against bacteria involved in mixed infections. Int J Antimicrob Agents 1999; 12 Suppl 1: S9-14; discussion S26-7.
35. Sommer MO, Church GM, Dantas G. The human microbiome harbors a diverse reservoir of antibiotic resistance genes. Virulence 2010; 1: 299-303.
36. Sommer MO, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009; 325: 1128-31.
37. Wright GD. Antibiotic resistance in the environment: a link to the clinic? Curr Opin Microbiol 2010; 13: 589-94.
38. Morar M, Pengelly K, Koteva K et al. Mechanism and diversity of the erythromycin esterase family of enzymes. Biochemistry (Mosc) 2012; 51: 1740-51.
39. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-92.
40. Wachino J, Yamane K, Suzuki S et al. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother 2010; 54: 3061-4.
41. Couce A, Briales A, Rodriguez-Rojas A et al. Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost. Antimicrob Agents Chemother 2012; 56: 2767-9.
42. Magalhaes ML, Blanchard JS. Aminoglycosides: mechanisms of action and resistance. In: Mayers DL, Lerner SA, Ouelette M et al., eds. Antimicrobial Drug Resistance. New York: Humana Press, 2009; 171-81.
43. Yang W, Moore IF, Koteva KP et al. TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J Biol Chem 2004; 279: 52346-52.
44. Drawz SM, Bonomo RA. Three decades of b-lactamase inhibitors. Clin Microbiol Rev 2010; 23: 160-201.
45. Zankari E, Hasman H, Cosentino S et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012; 67: 2640-4.